BioBridgeXAll companies

Insilico Medicine

Contract research organization (CRO) · Rockville, Maryland, United States

Insilico Medicine is a contract research organization (CRO) headquartered in Rockville, Maryland, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2018.

insilico.comProfile compiled from public records. Is this your company? Request a correction or update

Insilico Medicine at a glance

Typecontract research organization (CRO)
HeadquartersRockville, Maryland, United States
Earliest incorporation on record2014
SEC CIK1698493

What does Insilico Medicine do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $6 million sold (2018).

Insilico Medicine on the BioBridgeX marketplace

CRO · Target ID & Validation, Hit-to-Lead, Lead Optimization

Services

Target ID & ValidationHit-to-LeadLead OptimizationComputational / AI-Driven DiscoveryMedicinal & Synthetic Chemistry

Therapeutic areas

OncologyRespiratoryImmunology & InflammationCNS / NeurologyRare / Orphan Disease

Modalities

Small Molecule
Compare quotes

Unclaimed listing. Claim this profile

Frequently asked questions about Insilico Medicine

Where is Insilico Medicine headquartered?

Insilico Medicine is headquartered in Rockville, Maryland, United States.

What does Insilico Medicine do?

Insilico Medicine is a contract research organization (CRO).

When was Insilico Medicine founded?

The earliest incorporation on record for Insilico Medicine is in 2014, according to public company registers.

Similar companies

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.